Acorda Therapeutics is a biotechnology company based in Ardsley, New York, USA. The company develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda manufactures and markets the drugs Zanaflex, Ampyra and Qutenza in the United States.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| assets ($) |
|
| equity ($) |
|
| founding year |
|
| industry | |
| location city | |
| net income ($) |
|
| number of employees |
|
| operating income ($) |
|
| product | |
| revenue ($) |
|
| type |